JIANMIN GROUP: Furosemide oral solution approved for market launch
According to the Zhitong Finance APP, JIANMIN GROUP announced that the oral solution of Furosemide developed by the company has been approved for marketing by the National Medical Products Administration. The approval of the chemical generic drug oral solution of Furosemide will further enrich the company's product line, enhance the company's core competitiveness, and have a positive impact on the company's future development
According to the announcement from JIANMIN GROUP (600976.SH), the company recently learned from the National Medical Products Administration website that its developed oral solution of Furosemide has been approved for market launch. The approval of the chemical generic drug oral solution of Furosemide developed by the company will further enrich the company's product line, enhance the company's core competitiveness, and have a positive impact on the company's future development
